Page 6 of 32 · 745 questions tagged clinical-trials.
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I want to know whether there is evidence behind this or only…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I can parse the result. I am less sure what it licenses me to conclude. I…
What I have: reflux · semaglutide · STEP 3. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I am working with: oral semaglutide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
For reference: STEP 3 · hair thinning. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Conditions: semaglutide · STEP 1. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
For reference: 15 mg · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than on…
The particulars: PIONEER-1 · nausea · 14 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: fatigue · semaglutide · STEP 5. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: 1 mg · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
The case in front of me: SURMOUNT-3 · reflux. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: REDEFINE-1 · reflux. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
I have three data points across nine months, which I hope is enough to see a trend. I have the document in front of me and I can read the numbers. What I cannot do is…
The case in front of me: hair thinning · tirzepatide · SURMOUNT-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
I am trying to understand the logic of putting glucagon receptor agonism into a weight-loss molecule, because on the face of it it sounds like a mistake. Glucagon…
What I have: FLOW · headache · 2 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The case in front of me: REDEFINE-1 · injection-site erythema · 2.4 mg. The figures are clear enough; the question is what they mean and what they do not. I can…
Concretely: SURMOUNT-1 · vomiting. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change…
Stated plainly: STEP 1 · dizziness · 2 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
The case in front of me: STEP 2 · injection-site erythema · 2 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
Stated plainly: SURMOUNT-1 · reflux · 10 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
The particulars: oral semaglutide · minus 80 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I…
The clinician who ordered the panel was not concerned; I would still like to understand it. The units are where I keep going wrong, so please be explicit about them.…
Conditions: SURMOUNT-5 · dizziness. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…